The nine Cambridge researchers were all selected for their exceptional contributions to science.

Three Cambridge researchers are among six leading UK scientists who will share the presenting duties with Professor Jonathan Van-Tam during this year’s Christmas Lectures from the Royal Institution.

Findings suggest infection control measures against variants will need to continue in the post-vaccination era. 

One of the key mutations seen in the ‘Alpha variant’ of SARS-CoV-2 – the deletion of two amino acids, H69/V70 – enables the virus to overcome cracks in its armour as it evolves, say an international team of scientists.

Curriculum reforms which mix the arts and sciences will better prepare young people for the real-world challenges that will define their adult lives, researchers argue.

SARS-CoV-2 mutations similar to those in the B1.1.7 UK variant could arise in cases of chronic infection, where treatment over an extended period can provide the virus multiple opportunities to evolve, say scientists.

Dolutegravir, the current first-line treatment for HIV, may not be as effective as hoped in sub-Saharan Africa, suggests new research published on World AIDS Day. The study finds that this so-called ‘wonder drug’ may be less effective in patients resistant to older drugs.